• Profarma held an extraordinary shareholder meeting on July 15, 2026.
• Shareholders accepted the resignation of board member Jonathan Matthew McGowens, effective June 12, 2026.
• Shareholders authorized the appointment of François Mandeville to fill the vacant board seat through the 2028 annual meeting.
• The appointment was authorized but will take effect only once required eligibility statements are delivered and a formal acceptance term is signed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profarma Distribuidora de Produtos Farmacêuticos SA published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.